Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 3,706,004 4.800% | -558,998 (-13.11%) | Filing History |
| 2022-02-09 2:29 pm Purchase | 2021-12-31 | 13G | CRISPR Therapeutics AG CRSP | ARK Investment Management LLC | 9,087,868 11.880% | 1,443,518 (+18.88%) | Filing History |
| 2022-02-04 06:05 am Purchase | 2021-12-31 | 13G | CRISPR Therapeutics AG CRSP | Sumitomo Mitsui Trust Group, Inc. | 4,319,471 5.640% | 482,648 (+12.58%) | Filing History |
| 2021-09-10 2:47 pm Sale | 2021-08-31 | 13G | CRISPR Therapeutics AG CRSP | ARK Investment Management LLC | 7,644,350 10.030% | -2,768,626 (-26.59%) | Filing History |
| 2021-08-10 12:28 pm Sale | 2021-08-10 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 4,265,002 5.600% | -3,361,353 (-44.08%) | Filing History |
| 2021-02-16 4:33 pm Purchase | 2020-12-31 | 13G | CRISPR Therapeutics AG CRSP | ARK Investment Management LLC | 10,412,976 14.620% | 1,955,656 (+23.12%) | Filing History |
| 2021-02-16 3:58 pm Purchase | 2021-02-16 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 7,626,355 10.700% | 106,552 (+1.42%) | Filing History |
| 2021-02-16 07:33 am Purchase | 2020-09-29 | 13D | CRISPR Therapeutics AG CRSP | Versant Ventures IV LLC | 1,344,010 1.900% | 1,344,010 (New Position) | Filing History |
| 2021-02-11 5:14 pm Purchase | 2020-12-31 | 13G | CRISPR Therapeutics AG CRSP | Amova Asset Management Americas, Inc. | 3,836,823 5.390% | 787,270 (+25.82%) | Filing History |
| 2021-02-05 06:10 am Purchase | 2020-12-31 | 13G | CRISPR Therapeutics AG CRSP | Sumitomo Mitsui Trust Group, Inc. | 3,836,823 5.390% | 786,938 (+25.80%) | Filing History |